Literature DB >> 17464564

Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C.

Zeki Karasu1, Fatih Tekin, Galip Ersoz, Fulya Gunsar, Yucel Batur, Tankut Ilter, Ulus S Akarca.   

Abstract

Thrombocytopenia is a common complication of chronic liver diseases, but its pathogenesis is not clear. Although generally attributed to hypersplenism, other factors should also be considered. We investigated the relationship between the peripheral platelet count and the degree of fibrosis in patients with chronic viral hepatitis. In an effort to avoid the effects of hypersplenism, we excluded patients with splenomegaly and/or bi- or pan-cytopenia. Seven hundred eighty-four patients (265 chronic viral hepatitis C and 519 chronic viral hepatitis B) were included in the study. Univariate analysis showed that the peripheral platelet count had a negative correlation with fibrosis score, necroinflammatory activity, and age in both groups. In multivariate analysis, the peripheral platelet count had a similar correlation with the fibrosis score and age, but not with necroinflammatory activity, in both groups. The peripheral platelet count decreased more significantly in females with chronic hepatitis C but not in the chronic hepatitis B group. In conclusion, a decrease in peripheral platelet count may be a sign of an increase in the degree of fibrosis during the course of chronic viral hepatitis B and C and factors other than hypersplenism may play a role in this decrease in the peripheral platelet count.

Entities:  

Mesh:

Year:  2007        PMID: 17464564     DOI: 10.1007/s10620-006-9144-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  39 in total

1.  The pathogenesis of splenomegaly in hypertension of the portal circulation; congestive splenomegaly.

Authors:  E MOSCHCOWITZ
Journal:  Medicine (Baltimore)       Date:  1948-05       Impact factor: 1.889

Review 2.  Hepatitis B and C viruses and hepatocellular carcinoma.

Authors:  M C Kew
Journal:  Clin Lab Med       Date:  1996-06       Impact factor: 1.935

3.  [Thrombocytopenia and liver cirrhosis].

Authors:  W Frick
Journal:  Schweiz Med Wochenschr       Date:  1967-04-01

4.  Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism.

Authors:  A Marni; C Trojsi; L Belli
Journal:  Am J Surg       Date:  1981-09       Impact factor: 2.565

5.  Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma.

Authors:  M Okubo; G Shiota; H Kawasaki
Journal:  Clin Sci (Lond)       Date:  2000-09       Impact factor: 6.124

6.  Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation.

Authors:  T G Martin; K A Somberg; Y G Meng; R L Cohen; C A Heid; F J de Sauvage; M A Shuman
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

7.  Correction of hypersplenism following distal splenorenal shunt.

Authors:  J Ferrara; E C Ellison; E W Martin; M Cooperman
Journal:  Surgery       Date:  1979-10       Impact factor: 3.982

8.  Inter-relationships between platelet count, platelet IgG, serum IgG, immune complexes and severity of liver disease.

Authors:  R de Noronha; B A Taylor; G Wild; D R Triger; M Greaves
Journal:  Clin Lab Haematol       Date:  1991

9.  Effect of operations for variceal hemorrhage on hypersplenism.

Authors:  N J Soper; L F Rikkers
Journal:  Am J Surg       Date:  1982-12       Impact factor: 2.565

10.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  19 in total

1.  Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly.

Authors:  Kazuaki Tejima; Ryota Masuzaki; Hitoshi Ikeda; Haruhiko Yoshida; Ryosuke Tateishi; Yosuke Sugioka; Yukio Kume; Tomoko Okano; Tomomi Iwai; Hiroaki Gotoh; Sachiko Katoh; Atsushi Suzuki; Yukako Koike; Yutaka Yatomi; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2010-03-26       Impact factor: 7.527

2.  Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly.

Authors:  Yunfu Lv; Wan Yee Lau; Hongfei Wu; XiaoYu Han; Xiaoguang Gong; Ning Liu; Jie Yue; Qingqing Li; YeJuan Li; Jie Deng
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

Review 3.  Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis.

Authors:  Qing Pang; Kai Qu; Jian-Bin Bi; Su-Shun Liu; Jing-Yao Zhang; Si-Dong Song; Ting Lin; Xin-Sen Xu; Yong Wan; Ming-Hui Tai; Hao-Chen Liu; Ya-Feng Dong; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

4.  Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.

Authors:  Qing Pang; Jing-Yao Zhang; Xin-Sen Xu; Si-Dong Song; Kai Qu; Wei Chen; Yan-Yan Zhou; Run-Chen Miao; Su-Shun Liu; Ya-Feng Dong; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

5.  Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers.

Authors:  Sang Kyun Yu; Oh Sang Kwon; Hyuk Sang Jung; Kyung Suk Bae; Kwang An Kwon; Yu Kyung Kim; Yun Soo Kim; Ju Hyun Kim
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

6.  Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.

Authors:  Diana V Stefanova-Petrova; Anelia H Tzvetanska; Elisaveta J Naumova; Anastasia P Mihailova; Evgenii A Hadjiev; Rumiana P Dikova; Mircho I Vukov; Konstantin G Tchernev
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

7.  Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C.

Authors:  Ying Yuan; Ichiro Shimizu; Mi Shen; Eriko Aoyagi; Hidetaka Takenaka; Tatuzo Itagaki; Mari Urata; Katsutaka Sannomiya; Nao Kohno; Katsuyoshi Tamaki; Masayuki Shono; Tetsuji Takayama
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

8.  Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease.

Authors:  Mahmoud Saif-Al-Islam; Usama M Abdelaal; Mustafa Adel Younis; Hisham A Alghany Algahlan; Safaa Khalaf
Journal:  Gastroenterol Res Pract       Date:  2021-05-23       Impact factor: 2.260

9.  Splenic siderotic nodules in patients with liver cirrhosis.

Authors:  Huang-Qing Ouyang; Zuo-Jiong Gong; Yun-Fei Zha; Chang-Sheng Liu; Zhao-Hui Yang
Journal:  Exp Ther Med       Date:  2013-05-31       Impact factor: 2.447

10.  Usefulness of Noninvasive Predictors of Oesophageal Varices in Black African Cirrhotic Patients in Côte d'Ivoire (West Africa).

Authors:  Alassan Kouamé Mahassadi; Fulgence Yao Bathaix; Constant Assi; Aboubacar Demba Bangoura; Emile Allah-Kouadio; Henriette Ya Kissi; Abdoulaye Touré; Stanislas Doffou; Issa Konaté; Alain Koffi Attia; Mathieu Benoit Camara; Thérèse Aya Ndri-Yoman
Journal:  Gastroenterol Res Pract       Date:  2012-07-22       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.